HAZLET, N.J. - eTradeWire -- In this educational initiative, the current definition and clinical impact of WHF will be described, and principles of management explained. A panel discussion with WHF experts will provide practical guidance for diagnosing WHF, using GDMT in patients with worsening HFrEF, identifying patients for consideration of additional therapy, and strategies for utilizing additional medications in "real-world" practice.

The educational objectives include:

• Recognize the current definition of worsening heart failure and its adverse outcomes
• Describe best practices for using quadruple GDMT for patients with worsening HFrEF
• Interpret evidence for additional therapies on top of quadruple GDMT for the treatment of patients with recent WHF
• Explain optimal strategies for the management of worsening HFrEF

Click here for more information

More on eTradeWire News

• Topophilia: Love of a place | Exhibition featuring ceramicist Katharine Eksuzian
• Hidden Stitch Supply Adds Real Simons 20oz Red Plaid Wool Shirt
• Candor Annual: 20% off your first year through November 30, then 10% off in December
• Malcolm Holley Celebrates Mad About Sax Album Release at Chicago's The Record Track
• Coming Up on CNBC: Bilha Wachira Is Transforming Financial Literacy and Protection for America's Underserved Communities

CHAIR

Javed Butler, MD, MPH, MBA
President, Baylor Scott and White Research Institute
Dallas, Texas
Distinguished Professor of Medicine
University of Mississippi
Jackson, Mississippi

FACULTY

Nancy Albert, PhD, CCNS, CHFN, CCRN, NE-BC
Associate Chief Nursing Office
—Research and Innovation Clinical Nurse Specialist—
Kaufman Center for Heart Failure
Cleveland Clinic
Cleveland, Ohio

Stephen Greene, MD
Associate Professor of Medicine
Duke University School of Medicine
Duke Clinical Research Institute
Durham, North Carolina

Robert Page, PharmD, MSPH
Professor, Departments of Clinical Pharmacy and Physical Medicine
Skaggs School of Pharmacy and Pharmaceutical Sciences
CU Anschutz
Aurora, Colorado

This educational activity is intended for clinicians who manage patients with heart failure.

Voxmedia International gratefully acknowledges the educational grant provided by Merck & Co., Inc.

Voxmedia LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

More on eTradeWire News

• Counter-drone technology is being rushed to market. Buyers and investors must verify what it can do
• Award-Winning SoSco Duo to Perform Intimate Beatles Tribute at The Listening Room in Fountain Hills
• Santa's Christmas Eve Problem Calls for Pharmacist Flo in New Children's Book
• Des Moines Company Launches Electric Work and Personal Vehicles Built Only When Ordered
• Children's Series Adds a Holiday Tale!

Voxmedia LLC designates this live activity for a maximum of 1.00 AMA PRA Category Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurse practitioners may participate in this educational activity and earn a certificate of completion as AANP accepts AMA PRA Category 1 Credits ™ through its reciprocity agreements.
The National Commission on Certification of Physician Assistants accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.

Admission to this symposium is included with your registration for the 2024 Heart Failure Management Conference.